Would you boost a positive margin (R1 resection or R2 resection) in a GEJ esophageal carcinoma that completed neoadjuvant chemoradiation?   

What if the patient was not a candidate for additional chemotherapy?  Would your answer change if the patient received the CROSS regimen with <50 Gy?  



Answer from: Radiation Oncologist at Academic Institution